SCLC is usually diagnosed based on immunohistochemical examination for neuroendocrine markers such as chromogranin, synaptophysin, or CD56, in addition to morphological hematoxylin-eosin staining using transbronchial biopsy specimens. This evidence concerns the gene SYP and small cell lung carcinoma.